Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.55 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | AXL | P30530 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9861978 | 0.88 | CA2 (0.77) | CA2GABRA1GABRB2ALDH1A1TDP1 | |
| SCHEMBL5515511 | 0.87 | ALDH1A1 (0.52) | CA2GABRA1GABRB2LMNAGAA | |
| SCHEMBL8007178 | 0.87 | PDK2 (0.44) | CA2GABRA1GABRB2LMNAGAA | |
| SCHEMBL20600777 | 0.85 | ALB (0.43) | CA2GABRA1GABRB2LMNAGAA | |
| SCHEMBL23324839 | 0.83 | CA2 (0.39) | CA2GABRA1GABRB2LMNAGAA | |
| SCHEMBL3177363 | 0.83 | GABRA1 (0.65) | CA2GABRA1GABRB2GAAALDH1A1 | |
| SCHEMBL1603128 | 0.83 | CA2 (0.39) | CA2GABRA1GABRB2LMNAGAA | |
| SCHEMBL9860926 | 0.83 | SMN1; SMN2 (0.42) | CA2GABRA1GABRB2LMNAGAA | |
| SCHEMBL103733 | 0.83 | MMP2 (0.42) | CA2GABRA1GABRB2LMNAGAA | |
| SCHEMBL5312045 | 0.83 | CA2 (0.39) | CA2GABRA1GABRB2LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119953042-A | Organic photochromic glass and preparation process thereof | 上海匠心玻璃装饰工程有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-118085543-A | Copper-clad plate prepreg for high frequency and preparation method thereof | 上海华芯晟新材料有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-111363308-B | Epoxy modified low-dielectric fluorine-containing polyphenyl ether coating and high-frequency high-speed copper-clad plate prepared from same | 顺德职业技术学院 | 2022-12-23 | — | — | CN | claimed |
| CN-111471144-B | Acrylic acid modified low-dielectric fluorine-containing polyphenyl ether mixed glue and 5G copper-clad plate prepared from same | 顺德职业技术学院 | 2022-05-31 | — | — | CN | claimed |
| US-20140288249-A1 | Methods for Producing Polyolefins With Catalyst Systems | UNIVATION TECHNOLOGIES, LLC (US) | 2014-09-25 | — | — | US | claimed |
| EP-2776476-A1 | METHODS FOR PRODUCING POLYOLEFINS WITH CATALYST SYSTEMS | Univation Technologies, LLC (US) | 2014-09-17 | — | — | EP | claimed |
| CN-103930452-A | Process for producing polyolefins using a catalyst system | UNIVATION TECH LLC | 2014-07-16 | — | — | CN | claimed |
| WO-2013070602-A1 | METHODS FOR PRODUCING POLYOLEFINS WITH CATALYST SYSTEMS | UNIVATION TECHNOLOGIES, LLC (US) | 2013-05-16 | — | — | WO | claimed |
| EP-1113026-B1 | Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL CO (JP) | 2009-12-09 | — | — | EP | claimed |
| US-6620823-B2 | Antiinflammatory agents; rheumatic disorders | BRISTOL-MYERS SQUIBB PHARME COMPANY | 2003-09-16 | — | — | US | claimed |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| CN-119953042-A | Organic photochromic glass and preparation process thereof | 上海匠心玻璃装饰工程有限公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-4484407-A2 | (METH)ACRYLATE COMPOUND, ADDITIVE FOR OPTICAL RESIN, OPTICAL ELEMENT, AND OPTICAL DEVICE | NIKON CORPORATION (JP) | 2025-01-01 | — | — | EP | disclosed |
| CN-116082563-B | (Meth) acrylate compound, optical resin additive, optical element, and optical device | 株式会社 尼康 | 2024-09-20 | — | — | CN | disclosed |
| CN-118359760-A | Optical resin, optical element, and optical device | 株式会社 尼康 | 2024-07-19 | — | — | CN | disclosed |
| WO-2000059285-A2 | NOVEL LACTAM INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-10-12 | — | — | WO | disclosed |
| US-6057336-A | ANTIINFLAMMATORY AGENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0949273-A1 | MODIFIED PARTICLES, CARRIER PREPARED THEREFROM, OLEFIN POLYMERIZATION CATALYST COMPONENT PREPARED THEREFROM, OLEFIN POLYMERIZATION CATALYST PREPARED THEREFROM, AND PROCESS FOR PREPARING OLEFIN POLYMER | Sumitomo Chemical Company, Limited (JP) | 1999-10-13 | — | — | EP | disclosed |
| US-5629406-A | AMINO ACID DERIVATIVES | SANKYO COMPANY, LIMITED (JP) | 1997-05-13 | — | — | US | disclosed |
| EP-0587311-A1 | Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use | SANKYO COMPANY LIMITED (JP) | 1994-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | CD38, PARP9, MCCC2 | CA2 243/4885GABRA1 285/4885GABRB2 692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.